You are here: Home > Penny Stocks, Stock Reviews > APRE

APRE

Posted in Penny Stocks, Stock Reviews January 23rd, 20120Comments

APRE – Aperature Health, Inc.

On January 15 of this year, Aperture Health (formerly flexSCAN, Inc) announced that it had completed the acquisition of Triad Therapeutics, a homecare infusion therapy and nursing provider in New Jersey serving the tri-state area. As a result, Triad has become a wholly owned subsidiary of Aperture Health, Inc., and will remain as the operating company for the combined business.

Please begin your research at http://www.triadtx.net/

In case you’re wondering, APRE is trading at 30 cents per share.

Triad provides specialized home healthcare services to patients requiring intravenous therapy including antibiotics, pain management, hydration, immunoglobulins, steroids, total nutritional solutions, and IV catheter insertions and maintenance. The Company provides a complete solution to patients including
IV Therapy, Supplies, and Equipment
Antibiotic Therapy
Total Parental Nutrition
Total Enteral Nutrition
Hydration Solutions
Pain Management
Human Growth Hormone
Pentamidine
Prolastine

Triad is a fully JCAHO accredited home IV therapy company, achieving this “gold standard” status in 2007. The company has built a well respected reputation in its industry for its therapy expertise and commitment to care for its patient clients. The company services clients throughout the states of New Jersey, New York and Connecticut, providing opportunity for organic growth.

All patient clients accepted to Triad’s service have been preapproved for care by the client’s health insurance provider. Triad maintains numerous managed care service provider contracts, many of which are part of “closed networks,” thus provide strong barriers to entry in the industry.

According to OTCMarkets.com, APRE has just 26,212,954 shares outstanding and a float 5,212,928 as of December 23, 2011. These numbers seem relatively low for stocks trading around 30 cents, so we won’t be surprised if APRE experiences above average volatility this week.

Make sure you’re watching APRE tomorrow ! Later on we’ll give you an idea of how big of industry APRE is operating in.

  • Digg
  • Del.icio.us
  • StumbleUpon
  • Reddit
  • Twitter
  • RSS

Comments are closed.

7

Sitemap | Privacy Policy | Terms of Service

Disclaimer: (Please Read) Never invest in any stock featured on the PennyStockWizard.net website or email alerts unless you can afford to lose your entire investment. Many of the stocks featured are highly speculative. The third party may have shares and may sell their shares at any time. Please understand that it is possible that this could have a negative effect on the share price. Neither Edmond nor PennyStockWizard.net employees are registered as investment advisors, financial analysts, brokers, or dealers in any jurisdiction whatsoever. Your use of the PennyStockWizard.net website, email alerts, and all other services means that you agree to hold PennyStockWizard.net, its operators, owners, and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may suffer. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation for the purchase or sale of any securities. The information provided is obtained from sources deemed reliable, but PennyStockWizard.net does not guarantee in any way the timeliness, sequence, accuracy, adequacy, or completeness of such information made regarding stocks discussed on PennyStockWizard.net or in email alerts. The owner, publisher, editor and their associates are not responsible for errors and omissions. You understand and agree that at the time of any transaction you make Edmond M., PennyStockWizard.net employees, PennyStockWizard.net affiliates, and friends and family of Edmond M. may have a position in such securities. The position may have been acquired prior to the publication of any website information or email alert. You should also be aware that the aforementioned parties do have the right to sell their positions at any time without further notification. Any opinions expressed are subject to change without notice. PennyStockWizard.net encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or persons affiliated with or associated with such companies; or is available from public sources.